Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Farber

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis and Related Disorders|April 17, 2015
Emergency Department visits before the diagnosis of MSRebecca Farber, Christine Hannigan, Megan Alcauskas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Objective and subjective measures of dalfampridine efficacy in clinical practiceSylvia Klineova, Rebecca Farber, Joshua Friedman, et al.
Pediatric Blood & Cancer|May 10, 2005
Retinitis following varicella in a vaccinated child with acute lymphoblastic leukemiaAshley Ross, Thomas W McLean, Rebecca Farber, et al.
Multiple Sclerosis and Related Disorders|July 30, 2021
Evaluation of ocrelizumab in older progressive multiple sclerosis patientsSamantha Epstein, Kathryn T Fong, Philip L De Jager, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Relationship between timed 25-foot walk and diffusion tensor imaging in multiple sclerosisSylvia Klineova, Rebecca Farber, Catarina Saiote, et al.
Neurology and Therapy|April 15, 2023
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE StudiesLilyana Amezcua, Yang Mao-Draayer, Wendy S Vargas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 28, 2020
Fatal COVID-19 in an MS patient on natalizumab: A case reportKathryn Rimmer, Rebecca Farber, Kiran Thakur, et al.
Multiple Sclerosis and Related Disorders|September 3, 2021
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapsesSamantha E Epstein, Seth Levin, Kaho Onomichi, et al.
Multiple Sclerosis and Related Disorders|December 19, 2021
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability DataSamantha Epstein, Zongqi Xia, Annie J Lee, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|April 17, 2015
Emergency Department visits before the diagnosis of MSRebecca Farber, Christine Hannigan, Megan Alcauskas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Objective and subjective measures of dalfampridine efficacy in clinical practiceSylvia Klineova, Rebecca Farber, Joshua Friedman, et al.
Pediatric Blood & Cancer|May 10, 2005
Retinitis following varicella in a vaccinated child with acute lymphoblastic leukemiaAshley Ross, Thomas W McLean, Rebecca Farber, et al.
Multiple Sclerosis and Related Disorders|July 30, 2021
Evaluation of ocrelizumab in older progressive multiple sclerosis patientsSamantha Epstein, Kathryn T Fong, Philip L De Jager, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Relationship between timed 25-foot walk and diffusion tensor imaging in multiple sclerosisSylvia Klineova, Rebecca Farber, Catarina Saiote, et al.
Neurology and Therapy|April 15, 2023
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE StudiesLilyana Amezcua, Yang Mao-Draayer, Wendy S Vargas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 28, 2020
Fatal COVID-19 in an MS patient on natalizumab: A case reportKathryn Rimmer, Rebecca Farber, Kiran Thakur, et al.
Multiple Sclerosis and Related Disorders|September 3, 2021
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapsesSamantha E Epstein, Seth Levin, Kaho Onomichi, et al.
Multiple Sclerosis and Related Disorders|December 19, 2021
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability DataSamantha Epstein, Zongqi Xia, Annie J Lee, et al.
Pageof 1